Colin Trask
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 7
- Lung Cancer Research Studies 6
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Neuroendocrine Tumor Research Advances 4
- Multiple and Secondary Primary Cancers 1
- Co-authors
- Stephen Spiro (6 shared papers)Jeffrey Tobias (6 shared papers)R L Souhami (5 shared papers)Peter Harper (5 shared papers)E.M. Bessell (2 shared papers)Lucinda Billingham (2 shared papers)A.D. Chetiyawardana (1 shared paper)N.H. Gower (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Radiotherapy and Oncology (2 papers)Journal of Clinical Oncology (2 papers)Clinical Radiology (1 paper)Cancer (1 paper)
- Partner nations
- United KingdomJamaica
In The Last Decade
Colin Trask
12 papers receiving 816 citations
Peers
Comparison fields: 5 of 61
- Oncology 462
- Pulmonary and Respiratory Medicine 408
- Epidemiology 174
- Obstetrics and Gynecology 29
- Reproductive Medicine 33
Countries citing papers authored by Colin Trask
This map shows the geographic impact of Colin Trask's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Trask with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Trask more than expected).
Fields of papers citing papers by Colin Trask
This network shows the impact of papers produced by Colin Trask. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Trask. The network helps show where Colin Trask may publish in the future.
Co-authors
The 25 scholars most cited alongside Colin Trask, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 363 | |
| 2 | 2006 | 132 | |
| 3 | 1994 | 107 | |
| 4 | 1982 | 53 | |
| 5 | 1985 | 48 | |
| 6 | 1983 | 45 | |
| 7 | 1985 | 44 | |
| 8 | 1986 | 42 | |
| 9 | 2003 | 22 | |
| 10 | 1985 | 21 | |
| 11 | 1980 | 10 | |
| 12 | Mitomycin,Ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life | 2001 | 6 |
About Colin Trask
Colin Trask is a scholar working on Oncology, Epidemiology, Surgery, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 893 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (4 papers), Hermeneutics and Narrative Identity (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), Multiple and Secondary Primary Cancers (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (462 citations), Pulmonary and Respiratory Medicine (408 citations), Epidemiology (174 citations), Obstetrics and Gynecology (29 citations) and Reproductive Medicine (33 citations). Colin Trask has collaborated with scholars based in United Kingdom and Jamaica. Frequent co-authors include Stephen Spiro, Jeffrey Tobias, R L Souhami, Peter Harper, E.M. Bessell, Lucinda Billingham, A.D. Chetiyawardana, N.H. Gower, D. Ferry and C.M. Woodroffe. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Radiotherapy and Oncology, Journal of Clinical Oncology, Clinical Radiology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.